Skip to content

Gyre Therapeutics, Inc. GYRE Prepaid & Other Current

Prepaid & Other Current at other companies

Eli Lilly logo
Eli LillyLLY
$13.63B-7.0%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$64.96M+179%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$1.22M+41.5%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$7.38M+82.1%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$25.75M+10.7%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$4.94M+31.3%

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
CapEx$178.0K+45.9%
Free cash flow$3.0M+1,296%

Valuation

See full
Market cap$694.58M-4.7%
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0.0×
Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s prepaid & other current?
Gyre Therapeutics, Inc. (GYRE) reported prepaid & other current of $3.76M in Q1 2026.
How has Gyre Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Gyre Therapeutics, Inc.'s prepaid & other current decreased by 53.9% year-over-year, from $8.16M to $3.76M.
What is the long-term trend for Gyre Therapeutics, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s prepaid & other current has grown at a -16.2% compound annual growth rate (CAGR), from $6.84M to $2.83M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.